Author

D. C. Bou-Habib

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:drug response / drug discovery· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. C. Ferreira· 4 shared C. Q. Sacramento· 4 shared J. R. Temerozo· 4 shared M. Mattos· 4 shared N. Fintelman-Rodrigues· 4 shared P. T. Bozza· 4 shared T. M. L. Souza· 4 shared C. R. R. Pao· 3 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

A. C. Ferreira

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologybioRxivJul 21, 2021

Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants.

C. Q. Sacramento, N. Fintelman-Rodrigues, S. S. G. Dias…·T. M. L. Souza

This paper shows mefloquine inhibits SARS-CoV-2 infection in relevant cells more effectively than chloroquine without promoting viral mutations.

DOI 10.3390/v14020374

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 22, 2020

Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators

S. S. Gomes Dias, V. S. Cardoso, A. C. Ferreira…·P. T. Bozza

This study shows that lipid droplets support SARS-CoV-2 replication and inflammatory mediator production, with DGAT-1 inhibition reducing viral replication and inflammation.

DOI 10.1101/2020.08.22.262733

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivJul 25, 2020

VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.

J. R. Temerozo, C. Q. Sacramento, N. Fintelman-Rodrigues…·D. C. Bou-Habib

The paper shows elevated VIP plasma levels in severe COVID-19 patients correlate with survival and protective effects against SARS-CoV-2 in vitro.

DOI 10.1002/jlb.5cova1121-626r

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 15, 2020

The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2

C. Q. Sacramento, N. Fintelman-Rodrigues, J. R. Temerozo…·T. M. L. Souza

This study evaluates the antiviral activity of daclatasvir and sofosbuvir against SARS-CoV-2 in vitro, showing inhibition of viral replication and associated pathologies.

DOI 10.1101/2020.06.15.153411

humanexperimental assay

𝕏 PostBluesky